Using Copy Number Alterations to Identify New Therapeutic Targets for Bladder Carcinoma
AbstractBladder cancer represents the ninth most widespread malignancy throughout the world. It is characterized by the presence of two different clinical and prognostic subtypes: non-muscle-invasive bladder cancers (NMIBCs) and muscle-invasive bladder cancers (MIBCs). MIBCs have a poor outcome with a common progression to metastasis. Despite improvements in knowledge, treatment has not advanced significantly in recent years, with the absence of new therapeutic targets. Because of the limitations of current therapeutic options, the greater challenge will be to identify biomarkers for clinical application. For this reason, we compared our array comparative genomic hybridization (array-CGH) results with those reported in literature for invasive bladder tumors and, in particular, we focused on the evaluation of copy number alterations (CNAs) present in biopsies and retained in the corresponding cancer stem cell (CSC) subpopulations that should be the main target of therapy. According to our data, CCNE1, MYC, MDM2 and PPARG genes could be interesting therapeutic targets for bladder CSC subpopulations. Surprisingly, HER2 copy number gains are not retained in bladder CSCs, making the gene-targeted therapy less interesting than the others. These results provide precious advice for further study on bladder therapy; however, the clinical importance of these results should be explored. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Conconi, D.; Sala, E.; Bovo, G.; Strada, G.; Dalprà, L.; Lavitrano, M.; Bentivegna, A. Using Copy Number Alterations to Identify New Therapeutic Targets for Bladder Carcinoma. Int. J. Mol. Sci. 2016, 17, 271.
Conconi D, Sala E, Bovo G, Strada G, Dalprà L, Lavitrano M, Bentivegna A. Using Copy Number Alterations to Identify New Therapeutic Targets for Bladder Carcinoma. International Journal of Molecular Sciences. 2016; 17(3):271.Chicago/Turabian Style
Conconi, Donatella; Sala, Elena; Bovo, Giorgio; Strada, Guido; Dalprà, Leda; Lavitrano, Marialuisa; Bentivegna, Angela. 2016. "Using Copy Number Alterations to Identify New Therapeutic Targets for Bladder Carcinoma." Int. J. Mol. Sci. 17, no. 3: 271.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.